P2Y12 inhibitors: all 610 studies that test it
Page 3 of 7. Open to participants first (61), then studies with results posted, then the rest; newest registration first within each.
- Clopidogrel Versus Cilostazol in Ischemic StrokeCompletedNCT06242132Phase 3
- Ticagrelor Versus Clopidogrel in Large Vessel Ischemic StrokeCompletedNCT06120725Phase 3
- Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial HaemorrhageActive, not recruitingNCT05986968Not applicable
- Bioequivalence Study of Two Formulations of Clopidogrel Film-coated Tablets 75 mg in Healthy Male Subjects Under Fasting ConditionsCompletedNCT05934799Phase 1
- Ticagrelor vs. Clopidogrel in Post PCI PatientsCompletedNCT05858918Not applicable
- De-escalation of Ticagrelor in Post PPCIStatus unknownNCT05831462Phase 1/2
- Effects of Ticagrelor Versus Prasugrel on Coronary Microcirculation in Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the PROtecting MICROcirculation During Coronary Angioplasty (PROMICRO)-3 Randomised StudyCompletedNCT05643586Phase 4
- Ticagrelor Versus Clopidogrel in Ischemic StrokeCompletedNCT05553613Phase 3
- Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen OvaleCompletedNCT05546320Phase 2
- Impact of CYP2C19 Genotype-guided Clopidogrel and Ticagrelor Treatment on Platelet Function Test and Metabolomics ProfileCompletedNCT05516784Phase 4
- Testing P2Y12 Platelet Inhibitors Generics Beyond BioequivalenceCompletedNCT05474053Phase 3
- KF2019#1-trial: Effects of a Thrombocyte Inhibitor on a Cholesterol-lowering DrugStatus unknownNCT05373277Phase 1
- Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted CoilingCompletedNCT05257824Phase 4
- Platelet Aggregation and Adenosine Levels Among Patients Taking Ticagrelor or PrasugrelCompletedNCT05247385Phase 4
- Optimal Dosage of Ticagrelor in Korean Patients With AMIStatus unknownNCT05210595Phase 4
- Bioequivalence Study of Clopid® (Clopidogrel) 75 mg Tablet and Plavix® 75 mg Tablet After Oral Administration to Healthy Adult Subjects Under Fasting ConditionCompletedNCT05186129Phase 1
- Dual Antiplatelet Therapy in Patients With Clopidogrel Resistance Following Off-Pump Coronary Artery BypassStatus unknownNCT05166538Phase 4
- Ticagrelor Monotherapy After StentingCompletedNCT05149560Phase 2
- Effects of Edoxaban on Platelet AggregationCompletedNCT05122455Phase 2/3
- Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular AtherostenosisActive, not recruitingNCT05047172Phase 3
- 1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated BalloonActive, not recruitingNCT04971356Not applicable
- Comparison of the Efficacy of Ticagrelor Combined With ASA to ASA Alone in Patients With StrokeCompletedNCT04962451Phase 4
- Ticagrelor in Post-transplant Patients With Pediatric Hepatic Artery Thrombosis (HAT)Status unknownNCT04946929Phase 3
- The Accuracy Of A Novel Platelet Activity Assay In Humans On Antiplatelet Agents: Pharmacodynamics And Comparison With Light Transmission AggregometryCompletedNCT04822363Early Phase 1
- Rivaroxaban or Aspirin in Patients With CHD & GD Undergoing PCIStatus unknownNCT04805710Phase 4
- Optical Coherence Tomography-Guided PCI With Single-Antiplatelet TherapyCompletedNCT04766437Phase 2
- Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACSCompletedNCT04739384Phase 3
- Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic StrokeCompletedNCT04738097Phase 3
- Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary SyndromeStatus unknownNCT04718025Phase 3
- Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCIStatus unknownNCT04688723Phase 4
- Drug Interaction Study of MGL-3196 With ClopidogrelCompletedNCT04671069Phase 1
- REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEntsSuspendedNCT04667078Phase 3
- VerifyNow to Optimise Platelet Inhibition in Coronary Acute SyndromeCompletedNCT04654052Phase 4
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese SubjectsCompletedNCT04588727Phase 1
- SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3CompletedNCT04418479Phase 4
- Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial InfarctionCompletedNCT04369534Phase 4
- Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19CompletedNCT04368377Phase 2
- Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCIStatus unknownNCT04338919Not applicable
- Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.TerminatedNCT04333407Not applicable
- Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve ImplantationCompletedNCT04331145Phase 4
- A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus PatientsStatus unknownNCT04307511Phase 4
- Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease.WithdrawnNCT04293172Phase 3
- The Effects of loW Dose tIcagrelor on Platelet Function Testing in Patients With Stable Coronary arTery DiseaseCompletedNCT04206176Phase 1/2
- Ticagrelor in Remote Ischemic Preconditioning StudyCompletedNCT04174261Phase 4
- Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male VolunteersCompletedNCT04171687Phase 1
- Safety and Effectiveness of Ticagrelor in Patients Undergoing Carotid StentingStatus unknownNCT04091074Phase 1
- Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events IICompletedNCT04078737Phase 3
- Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention.WithdrawnNCT04069234Phase 3
- LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary InterventionStatus unknownNCT04060914Phase 4
- Ticagrelor Compared to Clopidogrel in Acute Coronary SyndromesCompletedNCT04057300Phase 4
- DUAL Antithrombotic Therapy in Patients With AF and ACSStatus unknownNCT04023630Phase 4
- Cangrelor in Comatose Survivors of OHCA Undergoing Primary PCICompletedNCT04005729Phase 4
- Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery DiseaseCompletedNCT04001894Phase 4
- Ticagrelol Versus Aspirin in Ischemic StrokeCompletedNCT03884530Phase 3
- Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACSCompletedNCT03881943Phase 4
- Maintenance Of aNtiplatElet Therapy in Patients With Coronary Stenting Undergoing Surgery (MONET BRIDGE)Status unknownNCT03862651Phase 2
- Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACSStatus unknownNCT03775746Phase 4
- Method of Clopidogrel Pre-treatment Undergoing Conventional Coronary Angiogram in Angina PatientsCompletedNCT03759067Not applicable
- Personalization of Long-Term Antiplatelet Therapy - RAPID EXTENDTerminatedNCT03729401Phase 4
- A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy SubjectsCompletedNCT03698513Phase 1
- Low-dose of Ticagrelor and Standard-dose Clopidogrel on Platelet Effects in Chinese Patients With Stable CAD.CompletedNCT03679091Phase 4
- Antiplatelet vs R-tPA for Acute Mild Ischemic StrokeCompletedNCT03661411Phase 4
- Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent ImplantationStatus unknownNCT03620760Phase 4
- Ticagrelor and Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With CHDStatus unknownNCT03614832Phase 4
- Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial AneurysmCompletedNCT03581409Phase 4
- The Optimal Strategy of Switching From Clopidogrel to Ticagrelor in Patients With Complexity of Coronary Artery DiseaseCompletedNCT03577652Not applicable
- Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage ClosureActive, not recruitingNCT03568890Phase 4
- Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary SyndromeActive, not recruitingNCT03560310Phase 4
- Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial InfarctionCompletedNCT03551964Phase 4
- A Clinical Study to Assess the Effect of Clopidogrel on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Male SubjectsCompletedNCT03496506Phase 1
- PK Study of Ticagrelor in Children Aged Less Than 24 Months, With Sickle Cell Disease (HESTIA4)CompletedNCT03492931Phase 1
- Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)CompletedNCT03487406Phase 2
- Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical TherapyCompletedNCT03463317Phase 4
- A Study of the Effect of Epinephrine on Platelet Reactivity in Subjects Treated With TicagrelorCompletedNCT03441412Phase 1
- Prasugrel vs. Ticagrelor on Myocardial Injury in STEMICompletedNCT03435133Not applicable
- Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients TrialCompletedNCT03431142Phase 4
- A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy SubjectsCompletedNCT03430661Phase 1
- Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on ClopidogrelCompletedNCT03392051Phase 1
- Low Dose Ticagrelor Versus Low Dose Prasugrel in Patients With Prior Myocardial InfarctionCompletedNCT03387826Phase 4
- Clopidogrel Response and CYP2C19 Genotype in Ischemic Stroke PatientsCompletedNCT03385538Phase 4
- TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.CompletedNCT03357874Phase 3
- The Safety and Efficacy Of Rivaroxaban and Ticagrelor for Patients With Atrial Fibrillation After Percutaneous Coronary InterventionCompletedNCT03331484Phase 3
- Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mgCompletedNCT03329261Phase 4
- A Study to Assess the Effect of Ticlopidine on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy ParticipantsCompletedNCT03298906Phase 1
- Clopidogrel Prevention of Early Arteriovenous (AV) Fistula ThrombosisCompletedNCT03289520Phase 3
- Add-on Cangrelor in STEMI-triggered Cardiac ArrestStatus unknownNCT03273075Phase 4
- Effectiveness of Lower Maintenance Dose of Ticagrelor Early After Myocardial Infarction (ELECTRA) Pilot StudyCompletedNCT03251859Phase 3
- Anti-platelet + Pembro for H&N TumorsCompletedNCT03245489Phase 1
- A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)TerminatedNCT03224923Phase 4
- Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent ImplantationCompletedNCT03198741Phase 4
- Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMIStatus unknownNCT03182855Phase 4
- Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKDStatus unknownNCT03150667Phase 4
- TIMES: Ticagrelor vs. Placebo/ Clopidogrel With Aspirin in Anterior STEMI Patients Treated With Primary PCIStatus unknownNCT03145194Phase 2
- A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are AdministeredCompletedNCT03126695Phase 1
- Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.Status unknownNCT03103685Phase 4
- Platelet Inhibition to Target Reperfusion InjuryStatus unknownNCT03102723Phase 2
- The Impact of Genotype on Pharmacokinetics and Antiplatelet Effects of Ticagrelor in Healthy ChineseCompletedNCT03092076Phase 1
- Ticagrelor Versus High-dose Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After PCIWithdrawnNCT03078465Phase 3
- Half-dose Ticagrelor Overcomes High-dose Clopidogrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet ReactivityStatus unknownNCT03062462Phase 2/3
- Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting StentsCompletedNCT03056118Phase 4